CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,577,000 | +28.2% | 63,530 | -7.2% | 0.02% | +11.1% |
Q4 2018 | $1,230,000 | -54.1% | 68,492 | -24.9% | 0.02% | -47.1% |
Q3 2018 | $2,677,000 | -44.7% | 91,156 | -14.3% | 0.03% | -49.3% |
Q2 2018 | $4,838,000 | -32.8% | 106,405 | -22.0% | 0.07% | -39.6% |
Q1 2018 | $7,199,000 | -37.6% | 136,348 | -19.7% | 0.11% | -33.5% |
Q4 2017 | $11,540,000 | -33.5% | 169,700 | -19.4% | 0.17% | -32.4% |
Q3 2017 | $17,356,000 | -17.1% | 210,627 | -5.8% | 0.25% | -22.3% |
Q2 2017 | $20,932,000 | +6.3% | 223,560 | -27.7% | 0.32% | -4.5% |
Q1 2017 | $19,685,000 | +36.1% | 309,169 | -5.0% | 0.33% | +19.4% |
Q4 2016 | $14,459,000 | – | 325,505 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |